PPCBPropanc Biopharma, Inc.

Propanc Biopharma, Inc.

PPCB· Nasdaq

PPCBPropanc Biopharma, Inc.

PPCB holders

Who holds Propanc Biopharma, Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.

Moves this quarter

Among the largest holders, against their report a quarter earlier.

Added—

Reduced

Jane Street Group, LLC−117.7K$38.3K

New

Citadel Advisors LLC12.1K$18.1K
HRT Financial LP10.2K$15
Caitong International Asset Management Co., Ltd2$3

Managers: 4
Shares held: 47.9K
Value held: $56.5K
Opened: 3
Closed: 5

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

Manager	Shares	Change	Value	Of portfolio	Filed
Jane Street Group, LLC	25.6K	−82.2%	$38.3K	0%	Aug 14, 2026
Citadel Advisors LLC	12.1K	New	$18.1K	0%	Sep 2, 2026
HRT Financial LP	10.2K	New	$15	0%	Aug 14, 2026
Caitong International Asset Management Co., Ltd	2	New	$3	0%	Aug 5, 2026